Smith & Nephew SNATS Inc (SNN)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $13.09B
Last updated: Nov 17, 2026 at 11:06 AM ET
Smith & Nephew SNATS Inc (SNN) Financials: Revenue, Profit and Cash Flow
Smith & Nephew SNATS reported revenue of $6.16B for the fiscal year ended Dec 31, 2025, up 6.1% from the year before. That year, net income was $625.00M with a net margin of 10.1%, operating cash flow was $1.28B and free cash flow was $852.00M. The quarter ended Jun 30, 2026 had revenue of $3.10B and net income of $303.00M.
Revenue and Margins
The operating margin was 12.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $4.67B, a compound annual rate of 3.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $6.16B | +6.1% | 68.3% | 12.9% | 10.1% |
| Dec 2024 | $5.81B | +4.7% | 70.2% | 11.3% | 7.1% |
| Dec 2023 | $5.55B | +6.4% | 70.2% | 7.7% | 4.7% |
| Dec 2022 | $5.21B | +0.1% | 70.9% | 8.6% | 4.3% |
| Dec 2021 | $5.21B | +14.3% | 71.0% | 11.4% | 10.1% |
| Dec 2020 | $4.56B | -11.2% | 69.7% | 6.5% | 9.8% |
| Dec 2019 | $5.14B | +4.8% | 74.1% | 15.9% | 11.7% |
| Dec 2018 | $4.90B | +2.9% | 73.5% | 17.6% | 13.5% |
| Dec 2017 | $4.76B | +2.1% | 73.8% | 19.6% | 16.1% |
| Dec 2016 | $4.67B | N/A | 72.8% | 17.2% | 16.8% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 51.7% from the year before. In the quarter ended Jun 2026, net income rose 3.4% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.16B | $5.81B | $5.55B | $5.21B | $5.21B | $4.56B | $5.14B | $4.90B | $4.76B | $4.67B |
| Cost of revenue | $1.96B | $1.73B | $1.65B | $1.51B | $1.51B | $1.38B | $1.33B | $1.30B | $1.25B | $1.27B |
| Gross profit | $4.21B | $4.08B | $3.90B | $3.70B | $3.70B | $3.18B | $3.81B | $3.61B | $3.52B | $3.40B |
| Research and development | $346.00M | $343.00M | $339.00M | $345.00M | $356.00M | $307.00M | $292.00M | $246.00M | $223.00M | $230.00M |
| Operating income | $794.00M | $657.00M | $425.00M | $450.00M | $593.00M | $295.00M | $815.00M | $863.00M | $934.00M | $801.00M |
| Net income | $625.00M | $412.00M | $263.00M | $223.00M | $524.00M | $448.00M | $600.00M | $663.00M | $767.00M | $784.00M |
| EBITDA | $1.45B | $1.44B | $1.27B | $1.21B | $1.27B | $978.00M | $1.48B | $1.40B | $1.31B | $1.33B |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.10B | $3.20B | $2.96B | $2.98B | $2.83B | $2.83B | $1.41B | $2.81B | $1.41B | $2.73B | $1.37B | $2.62B |
| Gross profit | $2.20B | $2.12B | $2.09B | $2.10B | $1.97B | $1.97B | $987.00M | $2.00B | $997.00M | $1.90B | $949.00M | $1.87B |
| Operating income | $448.00M | $365.00M | $429.00M | $329.00M | $328.00M | $328.00M | $164.00M | $150.00M | $203.50M | $275.00M | $137.50M | $208.00M |
| Net income | $303.00M | $332.00M | $293.00M | $198.00M | $214.00M | $214.00M | $107.00M | $91.00M | $45.50M | $172.00M | $86.00M | $46.00M |
Balance Sheet
As of Dec 2025, total debt of $3.18B exceeded cash and equivalents by $2.62B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $10.46B | $10.35B | $9.99B | $9.97B | $10.92B | $11.01B | $9.30B | $8.06B | $7.87B | $7.34B |
| Current assets | $4.10B | $4.42B | $4.03B | $3.86B | $4.42B | $4.66B | $3.22B | $3.08B | $2.73B | $2.53B |
| Cash and equivalents | $557.00M | $619.00M | $302.00M | $350.00M | $1.29B | $1.76B | $277.00M | $365.00M | $169.00M | $100.00M |
| Total liabilities | $5.17B | $5.09B | $4.77B | $4.71B | $5.35B | $5.73B | $4.16B | $3.19B | $3.22B | $3.39B |
| Short-term debt | $150.00M | $63.00M | $765.00M | $160.00M | $491.00M | $337.00M | $72.00M | $167.00M | $29.00M | $86.00M |
| Long-term debt | $3.03B | $3.12B | $2.17B | $2.56B | $2.71B | $3.21B | $1.83B | $1.30B | $1.42B | $1.56B |
| Shareholder equity | $5.29B | $5.26B | $5.22B | $5.26B | $5.57B | $5.28B | $5.14B | $4.87B | $4.64B | $3.96B |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $11.01B | $10.46B | $10.68B | $10.35B | $10.54B | $10.54B | $10.54B | $9.99B | $9.99B | $9.84B | $9.97B | $9.97B |
| Total liabilities | $5.83B | $5.17B | $5.15B | $5.09B | $5.34B | $5.34B | $5.34B | $4.77B | $4.77B | $4.61B | $4.61B | $4.71B |
| Cash and equivalents | $754.00M | $557.00M | $675.41M | $619.00M | $568.00M | $568.00M | $568.00M | $302.00M | $302.00M | $190.00M | $190.00M | $350.00M |
| Shareholder equity | $5.18B | $5.29B | $5.53B | $5.26B | $5.21B | $5.21B | $5.21B | $5.22B | $5.22B | $5.23B | $5.14B | $5.26B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 66.6% of operating cash flow. Dividends came to 38.7% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.28B | $987.00M | $608.00M | $468.00M | $877.00M | $935.00M | $1.17B | $931.00M | $1.09B | $849.00M |
| Capital expenditures | $433.00M | $381.00M | $427.00M | $358.00M | $408.00M | $443.00M | $408.00M | $347.00M | $376.00M | $320.00M |
| Free cash flow | $852.00M | $606.00M | $181.00M | $110.00M | $469.00M | $492.00M | $760.00M | $584.00M | $714.00M | $529.00M |
| Dividends paid | $330.00M | $327.00M | $327.00M | $327.00M | $329.00M | $328.00M | $318.00M | $321.00M | $269.00M | $279.00M |
| Investing cash flow | -$406.00M | -$569.00M | -$448.00M | -$472.00M | -$691.00M | -$606.00M | -$1.25B | -$378.00M | -$543.00M | -$383.00M |
| Financing cash flow | -$955.00M | -$86.00M | -$200.00M | -$926.00M | -$645.00M | $1.16B | $7.00M | -$371.00M | -$434.00M | -$529.00M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $450.00M | $889.00M | $396.00M | $749.00M | $238.00M | $238.00M | $119.00M | $495.00M | $247.50M | $56.50M | $56.50M | $130.50M |
| Capital expenditures | $190.00M | $294.00M | $139.00M | $209.00M | $172.00M | $172.00M | $86.00M | $260.00M | $130.00M | $83.50M | $83.50M | $92.50M |
| Free cash flow | $260.00M | $595.00M | $257.00M | $540.00M | $66.00M | $66.00M | $33.00M | $235.00M | $117.50M | -$27.00M | -$27.00M | $38.00M |
Frequently Asked Questions About SNN
What is Smith & Nephew SNATS's annual revenue?
Smith & Nephew SNATS reported revenue of $6.16B for the fiscal year ended Dec 31, 2025.
How fast is Smith & Nephew SNATS's revenue growing?
Revenue was up 6.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.7%.
Is Smith & Nephew SNATS profitable?
Yes. Smith & Nephew SNATS reported net income of $625.00M for the fiscal year ended Dec 31, 2025, with a net margin of 10.1%.
How much free cash flow does SNN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.28B minus capital expenditures of $433.00M produced free cash flow of $852.00M.
How much debt does Smith & Nephew SNATS have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $3.03B, short-term debt of $150.00M and cash and equivalents of $557.00M.
SNN pages: Overview, Dividends, Financials